Caribou Biosciences, Inc. (CRBU) earnings
CRBU earnings moved a median of +2.10% by the close. Quarterly and annual CRBU reports and results, each read against the price at its own news timestamp. Back to the CRBU overview →
23 measured CRBU earnings events.
Where these CRBU earnings landedvs 21 measured CRBU earnings reactions
| Middle 50% of CRBU earnings reactions | -3.85% to +4.91% |
|---|---|
| Median reaction (to close) | +2.10% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 CRBU earnings events with a measured close landed between -3.85% and +4.91%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Caribou Biosciences Reports Third Quarter 2026 Financial Results | Press release | +2.46% | +11.89% | |
| Form 10-Q Caribou Biosciences, For: Sep 30 | SEC filing · Form 10-Q | +2.46% | +11.89% | |
| Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -1.93% | -1.86% | |
| Form 10-Q Caribou Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -1.93% | -1.86% | |
| Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.26% | +2.10% | |
| Form 10-Q Caribou Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +0.26% | +2.10% | |
| Form 10-K Caribou Biosciences, For: Dec 31 | SEC filing · Form 10-K | +1.68% | +7.69% | |
| Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -7.39% | — | |
| Form 10-Q Caribou Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -7.39% | — | |
| Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -2.04% | +13.37% | |
| Form 10-Q Caribou Biosciences, For: Jun 30 | SEC filing · Form 10-Q | -2.04% | +13.37% | |
| Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +1.27% | -1.99% | |
| Form 10-Q Caribou Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +1.27% | -1.99% | |
| Form 10-K Caribou Biosciences, For: Dec 31 | SEC filing · Form 10-K | -0.89% | -4.46% | |
| Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -8.08% | +4.51% | |
| Form 10-Q Caribou Biosciences, For: Sep 30 | SEC filing · Form 10-Q | -8.08% | +4.51% | |
| Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +5.42% | -6.40% | |
| Form 10-Q Caribou Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +5.42% | -6.40% | |
| Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -2.47% | -3.85% | |
| Form 10-Q Caribou Biosciences, For: Mar 31 | SEC filing · Form 10-Q | -2.47% | -3.85% | |
| Form 10-K Caribou Biosciences, For: Dec 31 | SEC filing · Form 10-K | -7.40% | -29.89% | |
| Form 10-Q/A Caribou Biosciences, For: Jun 30 | SEC filing · Form 10-Q | +0.19% | +4.91% | |
| Form 10-Q/A Caribou Biosciences, For: Mar 31 | SEC filing · Form 10-Q | +0.19% | +4.91% |
Keep exploring
More CRBU: analyst actions → · SEC filings → · CRBU overview →